e-learning
resources
London 2016
Monday, 05.09.2016
Update on drug-resistant tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Rifampicin and INH monoresistance prevalence among Iraqi smear positive pulmonary tuberculosis cases
Mohammad Abdulrazaq (Bagdad, Iraq), Mohammad Abdulrazaq, Layth Salih, Ahmed Mankhi, Hayder Al-Sikafi, Hussain Aldoori, Amar Zaidan, Samer Ameen, Talal Rajeb
Source:
International Congress 2016 – Update on drug-resistant tuberculosis
Session:
Update on drug-resistant tuberculosis
Session type:
Thematic Poster
Number:
2676
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Mohammad Abdulrazaq (Bagdad, Iraq), Mohammad Abdulrazaq, Layth Salih, Ahmed Mankhi, Hayder Al-Sikafi, Hussain Aldoori, Amar Zaidan, Samer Ameen, Talal Rajeb. Rifampicin and INH monoresistance prevalence among Iraqi smear positive pulmonary tuberculosis cases. Eur Respir J 2016; 48: Suppl. 60, 2676
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Direct molecular testing for isoniazid and rifampicin resistance from respiratory specimens of patients with tuberculosis
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013
The MTBDRplus 2.0 for rapid diagnosis of multidrug-resistant tuberculosis among patients with high risk of TB resistance
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013
Implementation of rapid drug-susceptibility testing for patients at high risk of multidrug-resistant tuberculosis in Cambodia
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013
Frequency of rifampicin resistance in re-treatment cases of pulmonary tuberculosis using Gene-Xpert in a tertiary care hospital tuberculosis clinic
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
Spread of tuberculosis among household contacts of multi drug resistant tuberculosis (MDRTB) patients
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014
Linezolid in the treatment of patients with MDR TB and XDR TB
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Prevalence of fluoroquinolon-resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
MOTT as a cause of treatment failure in pulmonary tuberculosis
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013
MDR-TB treatment outcomes in HIV positive patients
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
Features of different M.tuberculosis strains that were isolated from MDR-TB patients in Kharkiv, Ukraine
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016
Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016
The death analysis of HIV-infected patients in the antituberculous hospital
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014
Mutations in the genes of drug-resistant mycobacterium tuberculosis in Uzbekistan
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014
Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015
Risk factor and resistance pattern of MDR TB among suspected cases of Oromia Region
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015
Detection of TB by smear microscopy and GeneXpert MTB/RIF assay in non expectorating pulmonary TB suspects and pleural TB in high prevalent low income setting
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
Genotypes of mycobacterium tuberculosis isolates from autopsy material of HIV-positive tuberculosis patients in Russia
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015
Gene-Xpert for rapid detection of MDR-TB in re-treatment cases;a comparison with standard culture and DST
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept